These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1642465)

  • 21. Cortical connections and the pathology of Alzheimer's disease.
    Pearson RC
    Neurodegeneration; 1996 Dec; 5(4):429-34. PubMed ID: 9117558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
    Francis PT; Sims NR; Procter AW; Bowen DM
    J Neurochem; 1993 May; 60(5):1589-604. PubMed ID: 8473885
    [No Abstract]   [Full Text] [Related]  

  • 23. The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease.
    Roth M
    Br Med Bull; 1986 Jan; 42(1):42-50. PubMed ID: 3513892
    [No Abstract]   [Full Text] [Related]  

  • 24. Electron-cytochemical study of acetylcholinesterase in the cerebral cortex in Alzheimer's disease.
    Vostrikov VM
    Neurosci Behav Physiol; 1987; 17(4):346-52. PubMed ID: 3683828
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathological correlates of dementia in Alzheimer's disease.
    Mann DM
    Neurobiol Aging; 1994; 15(3):357-60; discussion 379-80. PubMed ID: 7936062
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional rather than global pathology decides symptoms in senile dementia of Alzheimer's type.
    Brun A
    Neurobiol Aging; 1994; 15(3):367-8; discussion 379-80. PubMed ID: 7936065
    [No Abstract]   [Full Text] [Related]  

  • 27. Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder.
    Braak H; Braak E
    Neurobiol Aging; 1994; 15(3):355-6; discussion 379-80. PubMed ID: 7936061
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of neocortical nerve cell loss in Alzheimer's disease: reality or methodological artifact.
    Mufson EJ; Benzing WC
    Neurobiol Aging; 1994; 15(3):361-2; discussion 379-80. PubMed ID: 7936063
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuron numbers in Alzheimer's disease: cell-specific pathology.
    Hyman BT; Van Hoesen GW
    Neurobiol Aging; 1987; 8(6):555-6. PubMed ID: 3431631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyramidal neuron loss and "glycine-site therapy": a need for an animal model and study in late-life depression.
    Bowen DM; Francis PT; Lowe SL; Pangalos MN; Procter AW; Steele JE
    Neurobiol Aging; 1989; 10(5):616-8; discussion 618-20. PubMed ID: 2812239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: stereology in search of specific markers.
    Vogels OJ
    Neurobiol Aging; 1994; 15(3):373-5; discussion 379-80. PubMed ID: 7936067
    [No Abstract]   [Full Text] [Related]  

  • 32. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease.
    Hyman BT; Gomez-Isla T
    Neurobiol Aging; 1994; 15(3):353-4; discussion 379-80. PubMed ID: 7936060
    [No Abstract]   [Full Text] [Related]  

  • 33. Mapping the affective syndrome in Alzheimer's disease.
    Resende Ede P; Caramelli P
    Arq Neuropsiquiatr; 2015 Jul; 73(7):551-2. PubMed ID: 26200047
    [No Abstract]   [Full Text] [Related]  

  • 34. Critical comments on "Propionibacterium acnes in the cortex of patients with Alzheimer's disease" by H.H. Kornhuber (Eur Arch Psychiatry Clin Neurosci, 1996, 246:108-109).
    Bauer J; Gottfries GG; Förstl H
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(4):224-6. PubMed ID: 8832202
    [No Abstract]   [Full Text] [Related]  

  • 35. Toward a more objective biology.
    Cruz-Orive LM
    Neurobiol Aging; 1994; 15(3):377-8; discussion 379-80. PubMed ID: 7936068
    [No Abstract]   [Full Text] [Related]  

  • 36. Lecanemab slows Alzheimer's disease: hope and challenges.
    Mead S; Fox NC
    Lancet Neurol; 2023 Feb; 22(2):106-108. PubMed ID: 36681438
    [No Abstract]   [Full Text] [Related]  

  • 37. The status verrucosus of the cerebral cortex.
    BERTRAND I; GRUNER J
    J Neuropathol Exp Neurol; 1955 Oct; 14(4):331-47. PubMed ID: 13263947
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology.
    Ciranna L
    Curr Neuropharmacol; 2006 Apr; 4(2):101-14. PubMed ID: 18615128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment strategy for the corticocortical neuron pathology of Alzheimer's disease.
    Bowen DM; Francis PT; Procter AW; Halliwell JV; Mann DM; Neary D
    Ann Neurol; 1992 Jul; 32(1):112. PubMed ID: 1642465
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.